JUBILANT PHARMOVA LTD.

NSE : JUBLPHARMABSE : 530019ISIN CODE : INE700A01033Industry : Pharmaceuticals & DrugsHouse : Jubilant Bhartia
BSE1211.05-22.8 (-1.85 %)
PREV CLOSE ( ) 1233.85
OPEN PRICE ( ) 1216.05
BID PRICE (QTY) 1208.30 (1)
OFFER PRICE (QTY) 1210.20 (2)
VOLUME 11859
TODAY'S LOW / HIGH ( )1208.70 1250.85
52 WK LOW / HIGH ( )422 1309
NSE1211.00-23.25 (-1.88 %)
PREV CLOSE( ) 1234.25
OPEN PRICE ( ) 1225.00
BID PRICE (QTY) 1209.40 (2)
OFFER PRICE (QTY) 1211.05 (14)
VOLUME 161416
TODAY'S LOW / HIGH( ) 1207.00 1252.50
52 WK LOW / HIGH ( )422 1309.9
( in Million)
Select year
ParticularsMar2024Mar2023Mar2022Mar2021Mar2020
Profit Before Tax1705.00278.006304.4712120.1012105.31
Adjustment7554.007829.005794.747164.757607.38
Changes In working Capital2531.00543.00-1782.872499.00-1796.72
Cash Flow after changes in Working Capital11790.008650.0010316.3421783.8517915.97
Cash Flow from Operating Activities9713.006607.008375.4317842.6515429.38
Cash Flow from Investing Activities-6079.00-5444.00-3803.70-7390.14-3270.03
Cash Flow from Financing Activities-4325.00-1567.00-325.99-17093.86-10503.70
Net Cash Inflow / Outflow-691.00-404.004245.74-6641.351655.65
Opening Cash & Cash Equivalents10139.009838.005019.5712308.1410053.97
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANA-769.81NA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange Fluctuations116.00705.00572.88122.59598.52
Closing Cash & Cash Equivalent9564.0010139.009838.195019.5712308.14

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.